PLG and non-small cell lung carcinoma: The plasminogen Kringle5 domain may bind to sGRP78 of endothelia and tumor cells, reducing the proliferation and colony formation of non-small cell lung cancer (NSCLC) cells, and alleviating radiotherapy resistance (68).